Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-032674
Filing Date
2025-04-07
Accepted
2025-04-07 16:50:46
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 27560
2 EXHIBIT 99.2 tm2511687d1_ex99-2.htm EX-99.2 42922
  Complete submission text file 0001104659-25-032674.txt   72194
Mailing Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710
Business Address 27-31 AVENUE DU GENERAL LECLERC MAISONS ALFORT, CEDEX I0 94710 33153898789
Bpifrance Participations SA (Filed by) CIK: 0001581835 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320
Business Address 107 AVENUE DE LA REPUBLIQUE CHATILLON I0 92320 33(0)155427878
DBV Technologies S.A. (Subject) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-88701 | Film No.: 25818781
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)